CH618183A5 - - Google Patents

Download PDF

Info

Publication number
CH618183A5
CH618183A5 CH1580574A CH1580574A CH618183A5 CH 618183 A5 CH618183 A5 CH 618183A5 CH 1580574 A CH1580574 A CH 1580574A CH 1580574 A CH1580574 A CH 1580574A CH 618183 A5 CH618183 A5 CH 618183A5
Authority
CH
Switzerland
Prior art keywords
homo
acid
carbon
hydrogen
hydroxy
Prior art date
Application number
CH1580574A
Other languages
German (de)
English (en)
Inventor
Ulrich Dr Kerb
Rudolf Prof Dr Wiechert
Klaus Dr Kieslich
Karl Dr Petzoldt
Helmut Dr Wachtel
Dieter Dr Palenschat
Reinhard Dr Horowski
Gert Dr Paschelke
Wolfgang Dr Kehr
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2360443A external-priority patent/DE2360443A1/de
Priority claimed from DE19742445161 external-priority patent/DE2445161A1/de
Application filed by Schering Ag filed Critical Schering Ag
Publication of CH618183A5 publication Critical patent/CH618183A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J63/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008Expansion of ring D by one atom, e.g. D homo steroids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00Preparation of steroids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Steroid Compounds (AREA)
CH1580574A 1973-11-30 1974-11-28 CH618183A5 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2360443A DE2360443A1 (de) 1973-11-30 1973-11-30 D-homo-20-ketopregnane
DE19742445161 DE2445161A1 (de) 1974-09-19 1974-09-19 D-homo-20-ketopregnane ii

Publications (1)

Publication Number Publication Date
CH618183A5 true CH618183A5 (fr) 1980-07-15

Family

ID=25766200

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1580574A CH618183A5 (fr) 1973-11-30 1974-11-28

Country Status (14)

Country Link
US (1) US4045574A (fr)
JP (1) JPS5084561A (fr)
AT (1) AT347611B (fr)
CA (1) CA1030522A (fr)
CH (1) CH618183A5 (fr)
DD (1) DD115659A5 (fr)
DK (1) DK134348C (fr)
ES (1) ES432106A1 (fr)
FR (1) FR2253512B1 (fr)
GB (1) GB1494097A (fr)
IE (1) IE40423B1 (fr)
IL (1) IL46153A (fr)
NL (1) NL7415577A (fr)
SE (1) SE408426B (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879316A (en) * 1987-02-26 1989-11-07 The University Of Tennessee Research Corporation Interpenetrating polymer network ion exchange membranes and method for preparing same
US6787530B1 (en) 1996-08-23 2004-09-07 Monash University Use of pregnane-diones as analgesic agents
MXPA05001857A (es) * 2002-08-16 2005-06-03 Upjohn Co Intermedios esteroideos de 5-androsten-38-ol y procedimientos para su preparacion.
US20070066579A1 (en) * 2002-08-16 2007-03-22 White Michael J 5-androsten-3beta-ol steroid intermediates and processs for their preparation
HRP20190232T1 (hr) 2013-04-17 2019-03-22 Sage Therapeutics, Inc. 19-nor c3,3-disupstituirani c21-n-pirazolil steroidi i postupci za njihovu upotrebu
HRP20200995T1 (hr) 2013-04-17 2020-11-27 Sage Therapeutics, Inc. 19-nor neuroaktivni steroidi za metode liječenja
WO2014169831A1 (fr) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor-hétéroaryl-stéroïdes c21-c-liés c3,3-disubstitués et procédés d'utilisation de ceux-ci
US20160068563A1 (en) 2013-04-17 2016-03-10 Boyd L. Harrison 19-nor neuroactive steroids and methods of use thereof
SMT202100229T1 (it) 2013-07-19 2021-05-07 Sage Therapeutics Inc Steroidi neuroattivi, composizioni e loro usi
SMT202100048T1 (it) 2013-08-23 2021-03-15 Sage Therapeutics Inc Steroidi neuroattivi, composizioni e loro usi
WO2015195962A1 (fr) 2014-06-18 2015-12-23 Sage Therapeutics, Inc. Stéroïdes neuroactifs, leurs compositions et utilisations
AU2015331749A1 (en) 2014-10-16 2017-05-04 Sage Therapeutics, Inc. Compositions and methods for treating CNS disorders
JP6742308B2 (ja) 2014-10-16 2020-08-19 セージ セラピューティクス, インコーポレイテッド Cns障害を処置するための組成物および方法
ES2793237T3 (es) 2014-11-27 2020-11-13 Sage Therapeutics Inc Composiciones y métodos para el tratamiento de trastornos del SNC
SI3250210T1 (sl) 2015-01-26 2021-07-30 Sage Therapeutics, Inc. Sestavki in metode za zdravljenje CNS motenj
US10329320B2 (en) 2015-02-20 2019-06-25 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
AU2017296295B2 (en) 2016-07-11 2022-02-24 Sage Therapeutics, Inc. C7, C12, and C16 substituted neuroactive steroids and their methods of use
CN109689673B (zh) 2016-07-11 2023-03-14 萨奇治疗股份有限公司 C17、c20和c21取代的神经活性类固醇及其使用方法
AR114044A1 (es) * 2017-12-22 2020-07-15 Sage Therapeutics Inc Composiciones y métodos para el tratamiento de trastornos en el sistema nervioso central
BR112021010996A2 (pt) 2018-12-05 2021-08-31 Sage Therapeutics, Inc. Esteroides neuroativos e seus métodos de uso
KR102821994B1 (ko) 2019-01-08 2025-06-19 쳉두 캉홍 파마슈티칼 코., 엘티디. 스테로이드 화합물, 및 이의 용도와 제조방법
CN114206900A (zh) 2019-05-31 2022-03-18 萨奇治疗股份有限公司 神经活性类固醇及其组合物
AU2020302748A1 (en) 2019-06-27 2022-01-06 Sage Therapeutics, Inc. Compositions and methods for treating CNS disorders
CN114729000A (zh) * 2019-06-27 2022-07-08 萨奇治疗股份有限公司 用于治疗cns病症的化合物
CN114787174A (zh) * 2019-06-27 2022-07-22 萨奇治疗股份有限公司 用于治疗cns病症的组合物和方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2860158A (en) * 1954-10-18 1958-11-11 Sterling Drug Inc Compounds of the perhydrochrysene series and preparation thereof
US3686223A (en) * 1968-12-26 1972-08-22 Sterling Drug Inc D-homoestratrienes
US3833621A (en) * 1972-03-20 1974-09-03 Richardson Merrell Inc 3-keto-7(alpha,beta)-loweralkyl-delta5 steroids and process for preparing same

Also Published As

Publication number Publication date
SE408426B (sv) 1979-06-11
DK134348C (da) 1977-03-21
IL46153A0 (en) 1975-02-10
US4045574A (en) 1977-08-30
ATA950774A (de) 1978-05-15
DK604174A (fr) 1975-07-28
FR2253512A1 (fr) 1975-07-04
FR2253512B1 (fr) 1978-02-03
IL46153A (en) 1979-01-31
AT347611B (de) 1979-01-10
IE40423B1 (en) 1979-05-23
NL7415577A (nl) 1975-06-03
JPS5084561A (fr) 1975-07-08
GB1494097A (en) 1977-12-07
DD115659A5 (fr) 1975-10-12
ES432106A1 (es) 1976-11-01
IE40423L (en) 1975-05-30
AU7586774A (en) 1976-06-03
CA1030522A (fr) 1978-05-02
DK134348B (da) 1976-10-25
SE7414960L (fr) 1975-06-02

Similar Documents

Publication Publication Date Title
CH618183A5 (fr)
CH619268A5 (fr)
DE2360443A1 (de) D-homo-20-ketopregnane
DE2636405C2 (de) Δ↑1↑↑5↑-17α-Chloräthinyl- und -Propinylsteroide der Östranreihe, Verfahren zu ihrer Herstellung sowie diese enthaltende pharmazeutische Präparate
DE2445161A1 (de) D-homo-20-ketopregnane ii
DE2636404C2 (de) Δ↑1↑↑5↑-17α-Äthinylsteroide der Östranreihe, Verfahren zu ihrer Herstellung sowie diese enthaltende pharmazeutische Präparate
DE2453823A1 (de) Neue methylensteroide
DE2047071C3 (de) pregnadiene, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
DE1113690B (de) Verfahren zur Herstellung von in 11-Stellung durch sauerstoffhaltige Gruppen substituierten 16-Methyl-1, 4-pregnadien-17ª‡-ol-3, 20-dion-Verbindungen
AT254407B (de) Herstellung von Retrosteroiden
DE2651364A1 (de) Neue d-homosteroide
DE2506688A1 (de) D-homo-19-nor-20-ketopregnane und verfahren zu ihrer herstellung
DE2449327A1 (de) 7-hydroxy-oestradiole
DE2636407A1 (de) Delta hoch 15 -steroide
DE1170950B (de) Verfahren zur Herstellung von 16ª‡-Chlormethyl-?-pregnadien-11ª‰, 21-diol-3, 20-dion und seiner 21-Ester
CH617709A5 (fr)
DE1254148B (de) Verfahren zur Herstellung von 1-Dehydro-3-methylen-steroiden der Androstanreihe
DE1095276B (de) Verfahren zur Herstellung von therapeutisch wirksamen Steroidverbindungen
DE1195747B (de) Verfahren zur Herstellung neuer 16-Methylen-testosteron-derivate
DE1232141B (de) Verfahren zur Herstellung von in 16-Stellung substituierten 15-Dehydro-steroiden
DE1230798B (de) Verfahren zur Herstellung von delta 4- bzw. delta 1,4-9alpha-Fluor-16-halogenmethylen-3, 20-diketosteroiden
CH349978A (de) Verfahren zur mikrobiologischen 1-Dehydrierung von Steroiden
DE1212528B (de) Verfahren zur Herstellung von delta 1,4,6-16-Methylen-3, 20-diketo-steroiden
DE1222497B (de) Verfahren zur Herstellung von 17alpha-AEthoxy-6-chlor-6-dehydro-progesteron
DE1211187B (de) Verfahren zur Herstellung von delta 1,4- bzw. delta 1,4,6-6, 16-Dimethyl-15-dehydro-steroiden

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased